New CRISPR patent hearing continues high-stakes legal battle

Tilis

CRISPR-Cas9 gene editing complex, molecular structure. The CRISPR-Cas9 protein (orange) is used in genome engineering to cut DNA (deoxyribonucleic acid). It uses a guide RNA (ribonucleic acid) sequence (red) to cut DNA (blue) at a complementary cleavage site. For this illustration with labels, see image C038/6358.

https://www.science.org/content/article/new-crispr-patent-hearing-continues-high-stakes-legal-battle?utm_source=sfmc&utm_medium=email&utm_campaign=DailyLatestNews&utm_content=alert&et_rid=682362580&et_cid=4103718

Next: Economic and Environmental Benefits from International Cooperation on Climate Policies